The above diagram shows the color scheme of the layout in the main result page. The parent entities and officers are those entities, including individual and legal persons, have significant controls over the company in focus. The offspring entities and appointments are those entities that the company in focus can influence on.

Clicking the links on parent entities or officers, and offspring entities or managed companies will put them in focus and show upstream or downstream connections. In general, ascendant entities can be found by moving toward upstream, and descendant entities are by toward downstream. In this way, progenitor entities such as grandparent companies (parents of parent), sibling companies (children of parent), partner companies (parents of child), and progeny entities such as grandchild companies (children of child) can be found easily.

Parent entities and officers
Active 3
  • 1
    Podolsky, Craig
    Company Director born in February 1981
    Individual (10 offsprings)
    Officer
    2020-01-09 ~ now
    OF - Director → CIF 0
  • 2
    Mr Ian Jacobson
    Born in March 1960
    Individual (12 offsprings)
    Person with significant control
    2020-01-09 ~ now
    PE - Ownership of shares – More than 25% but not more than 50%CIF 0
    PE - Ownership of voting rights - More than 25% but not more than 50%CIF 0
  • 3
    Fraser-pye, Graham Julian
    Company Director born in March 1968
    Individual (17 offsprings)
    Officer
    2020-01-09 ~ now
    OF - Director → CIF 0
    Mr Graham Julian Fraser-pye
    Born in March 1968
    Individual (17 offsprings)
    Person with significant control
    2020-01-09 ~ now
    PE - Ownership of shares – More than 25% but not more than 50%CIF 0
    PE - Ownership of voting rights - More than 25% but not more than 50%CIF 0
parent relation
Company in focus

IOREK PHARMA LIMITED

Standard Industrial Classification
82990 - Other Business Support Service Activities N.e.c.
Brief company account
Intangible Assets
102,863 GBP2023-12-31
111,376 GBP2022-12-31
Debtors
95,139 GBP2023-12-31
129,273 GBP2022-12-31
Cash at bank and in hand
35,937 GBP2023-12-31
46,361 GBP2022-12-31
Current Assets
131,076 GBP2023-12-31
175,634 GBP2022-12-31
Creditors
Current, Amounts falling due within one year
-27,615 GBP2023-12-31
-33,027 GBP2022-12-31
Net Current Assets/Liabilities
103,461 GBP2023-12-31
142,607 GBP2022-12-31
Total Assets Less Current Liabilities
206,324 GBP2023-12-31
253,983 GBP2022-12-31
Equity
Called up share capital
4,057 GBP2023-12-31
4,057 GBP2022-12-31
Share premium
391,664 GBP2023-12-31
391,664 GBP2022-12-31
Retained earnings (accumulated losses)
-189,397 GBP2023-12-31
-141,738 GBP2022-12-31
Equity
206,324 GBP2023-12-31
253,983 GBP2022-12-31
Average Number of Employees
02023-01-01 ~ 2023-12-31
02022-01-01 ~ 2022-12-31
Intangible Assets - Gross Cost
Other than goodwill
127,692 GBP2022-12-31
Intangible Assets - Accumulated Amortisation & Impairment
Other than goodwill
24,829 GBP2023-12-31
16,316 GBP2022-12-31
Intangible Assets - Increase From Amortisation Charge for Year
Other than goodwill
8,513 GBP2023-01-01 ~ 2023-12-31
Intangible Assets
Other than goodwill
102,863 GBP2023-12-31
111,376 GBP2022-12-31
Other Debtors
Current
95,139 GBP2023-12-31
129,273 GBP2022-12-31
Trade Creditors/Trade Payables
Current
13,669 GBP2023-12-31
17,369 GBP2022-12-31
Other Creditors
Current
13,946 GBP2023-12-31
15,658 GBP2022-12-31
Creditors
Current
27,615 GBP2023-12-31
33,027 GBP2022-12-31

  • IOREK PHARMA LIMITED
    Info
    Registered number 12395202
    Cannon Place, 78 Cannon Street, London EC4N 6AF
    Private Limited Company incorporated on 2020-01-09 (5 years 6 months). The company status is Active.
    The last date of confirmation statement was made at 2025-01-08
    CIF 0
child relation
Offspring entities and appointments
Active 0
  • Not found in our database.
© 2022-2025 Polylogarithmic Technology Ltd. All rights reserved.
Contains public sector information retrieved at 24 April 2025 and licensed under the Open Government Licence v3.0.